LakeShore Biopharma Announces Fiscal Year 2025 Financial Results 2:55 PM EDT 7/31/2025 - Comtex BEIJING, July 31, 2025 /PRNewswire via COMTEX News Network/ -- -- Total revenue reached RMB615.0 million, representing 7.2% year-over-year growth -- Gross profit rose to RMB507.2 million, up 11.3% year-over-year -- Gross margin improved to 82.5% from 79.5% in Fiscal Year 2024 -- Total operating expenses decreased 34.2% year-over-year to RMB593.5 million -- EBITDA[1] and Adjusted EBITDA[2] were...